The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Moncada, S., Gryglewski, R., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,595
Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., et al. (2000) · JAMA · doi:10.1001/jama.284.10.1247 · Cited by 3,154
Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
Hamberg, M., Svensson, J., & Samuelsson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.2994 · Cited by 3,045
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519
Cyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
Solomon, S. D., McMurray, J. J. V., Pfeffer, M. A., Wittes, J., Fowler, R., Finn, P., Anderson, W. F., Zauber, A., Hawk, E., & Bertagnolli, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050405 · Cited by 2,052
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., & Herschman, H. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98774-0 · Cited by 1,789
Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L., & Simmons, D. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2692 · Cited by 1,707
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., & Vane, J. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11693 · Cited by 1,659
Self-citationThe Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,565
Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets
SMITH, J. B., & WILLIS, A. L. (1971) · Nature New Biology · doi:10.1038/newbio231235a0 · Cited by 1,521
Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7563 · Cited by 1,519
Self-citationHla, T., & Neilson, K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7384 · Cited by 1,465
McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123
Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery
Nussmeier, N. A., Whelton, A. A., Brown, M. T., Langford, R. M., Hoeft, A., Parlow, J. L., Boyce, S. W., & Verburg, K. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050330 · Cited by 1,092
Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen
FERREIRA, S. H., MONCADA, S., & VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231237a0 · Cited by 941
Graham, D. J., Campen, D., Hui, R., Spence, M., Cheetham, C., Levy, G., Shoor, S., & Ray, W. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17864-7 · Cited by 913
Coxibs and Cardiovascular Disease
FitzGerald, G. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048288 · Cited by 899
Harris, R. C., McKanna, J. A., Akai, Y., Jacobson, H. R., Dubois, R. N., & Breyer, M. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117620 · Cited by 860
Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
Jüni, P., Nartey, L., Reichenbach, S., Sterchi, R., Dieppe, P. A., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17514-4 · Cited by 846
Topper, J. N., Cai, J., Falb, D., & Gimbrone, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10417 · Cited by 843
cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase.
O'Banion, M. K., Winn, V. D., & Young, D. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4888 · Cited by 821
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
Cheng, Y., Austin, S. C., Rocca, B., Koller, B. H., Coffman, T. M., Grosser, T., Lawson, J. A., & FitzGerald, G. A. (2002) · Science · doi:10.1126/science.1068711 · Cited by 789
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773
NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2
Wallace, J. L., McKnight, W., Reuter, B. K., & Vergnolle, N. (2000) · Gastroenterology · doi:10.1053/gast.2000.16510 · Cited by 705
Schnitzer, T. J., Burmester, G. R., Mysler, E., Hochberg, M. C., Doherty, M., Ehrsam, E., Gitton, X., Krammer, G., Mellein, B., Matchaba, P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16893-1 · Cited by 701
Dekker, R. J., van Soest, S., Fontijn, R. D., Salamanca, S., de Groot, P. G., VanBavel, E., Pannekoek, H., & Horrevoets, A. J. G. (2002) · Blood · doi:10.1182/blood-2002-01-0046 · Cited by 692
Dai, G., Kaazempur-Mofrad, M. R., Natarajan, S., Zhang, Y., Vaughn, S., Blackman, B. R., Kamm, R. D., García-Cardeña, G., & Gimbrone, M. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406073101 · Cited by 664
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
Warner, T. D., & Mitchell, J. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0645rev · Cited by 614
Self-citationFailing the Public Health — Rofecoxib, Merck, and the FDA
Topol, E. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048286 · Cited by 599
Catella-Lawson, F., McAdam, B., Morrison, B. W., Kapoor, S., Kujubu, D., Antes, L., Lasseter, K. C., Quan, H., Gertz, B. J., & Fitzgerald, G. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 597
Aging-Induced Phenotypic Changes and Oxidative Stress Impair Coronary Arteriolar Function
Csiszar, A., Ungvari, Z., Edwards, J. G., Kaminski, P., Wolin, M. S., Koller, A., & Kaley, G. (2002) · Circulation Research · doi:10.1161/01.res.0000020401.61826.ea · Cited by 563
Dose-Related Kinetics of Aspirin: Presystemic Acetylation of Platelet Cyclooxygenase
Pedersen, A. K., & FitzGerald, G. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411083111902 · Cited by 558
Hemodynamic forces are complex regulators of endothelial gene expression
Resnick, N., & Cimbrone, M. A. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615157 · Cited by 542
Biomechanical activation of vascular endothelium as a determinant of its functional phenotype
García-Cardeña, G., Comander, J., Anderson, K. R., Blackman, B. R., & Gimbrone, M. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071052598 · Cited by 523
Solomon, D. H., Schneeweiss, S., Glynn, R. J., Kiyota, Y., Levin, R., Mogun, H., & Avorn, J. (2004) · Circulation · doi:10.1161/01.cir.0000127578.21885.3e · Cited by 509
Farkouh, M. E., Kirshner, H., Harrington, R. A., Ruland, S., Verheugt, F. W., Schnitzer, T. J., Burmester, G. R., Mysler, E., Hochberg, M. C., Doherty, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16894-3 · Cited by 490
Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme
Masferrer, J. L., Seibert, K., Zweifel, B., & Needleman, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3917 · Cited by 461
The development of COX2 inhibitors
Flower, R. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1034 · Cited by 459
Mamdani, M., Juurlink, D. N., Lee, D. S., Rochon, P. A., Kopp, A., Naglie, G., Austin, P. C., Laupacis, A., & Stukel, T. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16299-5 · Cited by 435
Reilly, I., & FitzGerald, G. (1987) · Blood · doi:10.1182/blood.v69.1.180.180 · Cited by 419
Ott, E., Nussmeier, N. A., Duke, P. C., Feneck, R. O., Alston, R. P., Snabes, M. C., Hubbard, R. C., Hsu, P. H., Saidman, L. J., & Mangano, D. T. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(03)00125-9 · Cited by 403
McCormick, S. M., Eskin, S. G., McIntire, L. V., Teng, C. L., Lu, C.-M., Russell, C. G., & Chittur, K. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171259298 · Cited by 385
Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions
Schönbeck, U., Sukhova, G. K., Graber, P., Coulter, S., & Libby, P. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65230-3 · Cited by 379
Cyclooxygenase-1 and -2–Dependent Prostacyclin Formation in Patients With Atherosclerosis
Belton, O., Byrne, D., Kearney, D., Leahy, A., & Fitzgerald, D. J. (2000) · Circulation · doi:10.1161/01.cir.102.8.840 · Cited by 377
Swan, S. K., Rudy, D. W., Lasseter, K. C., Ryan, C. F., Buechel, K. L., Lambrecht, L. J., Pinto, M. B., Dilzer, S. C., Obrda, O., Sundblad, K. J., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00002 · Cited by 339
Whelton, A., Fort, J. G., Puma, J. A., Normandin, D., Bello, A. E., & Verburg, K. M. (2001) · American Journal of Therapeutics · doi:10.1097/00045391-200103000-00003 · Cited by 334
Cyclo‐oxygenase‐2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
Mitchell, J. A., & Warner, T. D. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702897 · Cited by 321
Self-citationRenal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
ROSSAT, J., MAILLARD, M., NUSSBERGER, J., BRUNNER, H., & BURNIER, M. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70056-1 · Cited by 318
Rocca, B., Secchiero, P., Ciabattoni, G., Ranelletti, F. O., Catani, L., Guidotti, L., Melloni, E., Maggiano, N., Zauli, G., & Patrono, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112202999 · Cited by 317
Whelton, A., White, W. B., Bello, A. E., Puma, J. A., & Fort, J. G. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02661-9 · Cited by 310
Cyclooxygenase-3 (COX-3): Filling in the gaps toward a COX continuum?
Warner, T. D., & Mitchell, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222543099 · Cited by 302
Self-citationBaker, C. S. R., Hall, R. J. C., Evans, T. J., Pomerance, A., Maclouf, J., Creminon, C., Yacoub, M. H., & Polak, J. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.646 · Cited by 296
Brooks, A. R., Lelkes, P. I., & Rubanyi, G. M. (2002) · Physiological Genomics · doi:10.1152/physiolgenomics.00075.2001 · Cited by 291
Johnsen, S. P. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.9.978 · Cited by 288
Cyclooxygenase Inhibition and Cardiovascular Risk
Antman, E. M., DeMets, D., & Loscalzo, J. (2005) · Circulation · doi:10.1161/circulationaha.105.568451 · Cited by 282
Effects of Celecoxib and Naproxen on Renal Function in the Elderly
Whelton, A., Schulman, G., Wallemark, C., Drower, E. J., Isakson, P. C., Verburg, K. M., & Geis, G. S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.10.1465 · Cited by 280
DNA microarray analysis of gene expression in endothelial cells in response to 24-h shear stress
CHEN, B. P. C., LI, Y.-S., ZHAO, Y., CHEN, K.-D., LI, S., LAO, J., YUAN, S., SHYY, J. Y.-J., & CHIEN, S. (2001) · Physiological Genomics · doi:10.1152/physiolgenomics.2001.7.1.55 · Cited by 278
Acetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties
Kis, B., Snipes, J. A., & Busija, D. W. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085431 · Cited by 250
Capone, M. L., Tacconelli, S., Sciulli, M. G., Grana, M., Ricciotti, E., Minuz, P., Di Gregorio, P., Merciaro, G., Patrono, C., & Patrignani, P. (2004) · Circulation · doi:10.1161/01.cir.0000124715.27937.78 · Cited by 229
Praticò, D., Tillmann, C., Zhang, Z.-B., Li, H., & FitzGerald, G. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061607398 · Cited by 215
Boutaud, O., Aronoff, D. M., Richardson, J. H., Marnett, L. J., & Oates, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102588199 · Cited by 209
Sigthorsson, G., Simpson, R. J., Walley, M., Anthony, A., Foster, R., Hotz–Behoftsitz, C., Palizban, A., Pombo, J., Watts, J., Morham, S. G., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.33647 · Cited by 191
Riendeau, D., Charleson, S., Cromlish, W., Mancini, J. A., Wong, E., & Guay, J. (1997) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-75-9-1088 · Cited by 186
Territoriality in the White Rhinoceros (Ceratotherium simum) Burchell
OWEN-SMITH, N. (1971) · Nature · doi:10.1038/231294a0 · Cited by 166
Narrative Review: Aspirin Resistance and Its Clinical Implications
Sanderson, S., Emery, J., Baglin, T., & Kinmonth, A.-L. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00012 · Cited by 160
&NA; (2002) · Journal of Hypertension · doi:10.1097/00004872-200212000-00001 · Cited by 160
Okahara, K., Sun, B., & Kambayashi, J.-I. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.12.1922 · Cited by 159
A BAC-Based STS-Content Map Spanning a 35-Mb Region of Human Chromosome 1p35–p36
Chen, Y. Z., Hayashi, Y., Wu, J. G., et al. (2001) · Genomics · doi:10.1006/geno.2001.6511 · Cited by 154
Identification of a cyclooxygenase-related gene and its potential role in prostaglandin formation
Rosen, G. D., Birkenmeier, T. M., Raz, A., et al. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91819-6 · Cited by 152
Global Analysis of Shear Stress-Responsive Genes in Vascular Endothelial Cells
Ohura, N., Yamamoto, K., Ichioka, S., Sokabe, T., Nakatsuka, H., Baba, A., Shibata, M., Nakatsuka, T., Harii, K., Wada, Y., et al. (2003) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10.304 · Cited by 150
Tanaka, A., Hase, S., Miyazawa, T., Ohno, R., & Takeuchi, K. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041715 · Cited by 133
Gene expression profile of human endothelial cells exposed to sustained fluid shear stress
Wasserman, S. M., Mehraban, F., Kömüves, L. G., Yang, R., Tomlinson, J. E., Zhang, Y., Spriggs, F. P., & Topper, J. N. (2002) · Physiological Genomics · doi:10.1152/physiolgenomics.00102.2002 · Cited by 129
Cellular mechanisms of acetaminophen: role of cyclo‐oxygenase
Lucas, R., Warner, T. D., Vojnovic, I., & Mitchell, J. A. (2005) · The FASEB Journal · doi:10.1096/fj.04-2437fje · Cited by 128
Self-citationRoth, G. J., Machuga, E. T., & Ozols, J. (1983) · Biochemistry · doi:10.1021/bi00289a010 · Cited by 125
Inoue, H., Taba, Y., Miwa, Y., Yokota, C., Miyagi, M., & Sasaguri, T. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000028816.13582.13 · Cited by 123
The Association of Acetaminophen, Aspirin, and Ibuprofen with Respiratory Disease and Lung Function
McKeever, T. M., Lewis, S., Smit, H. A., Burney, P., Britton, J. R., & Cassano, P. A. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1269oc · Cited by 120
COX-2–Derived Prostacyclin Modulates Vascular Remodeling
Rudic, R. D., Brinster, D. R., Cheng, Y., Fries, S., Song, W., Austin, S. C., Coffman, T. M., & FitzGerald, G. A. (2005) · Circulation Research · doi:10.1161/01.res.0000170888.11669.28 · Cited by 116
Constitutive Cyclooxygenase-2 Expression in Healthy Human and Rabbit Gastric Mucosa
Zimmermann, K. C., Sarbia, M., Schrör, K., & Weber, A. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.3.536 · Cited by 113
Inhibition of Cyclooxygenase-2 in the Rat Renal Medulla Leads to Sodium-Sensitive Hypertension
Zewde, T., & Mattson, D. L. (2004) · Hypertension · doi:10.1161/01.hyp.0000140924.91479.03 · Cited by 98
Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans
Schwartz, J. I., CHAN, C., Mukhopadhyay, S., MCBRIDE, K., JONES, T., Adcock, S., MORITZ, C., Hedges, J. R., Grasing, K., & DOBRATZ, D. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)90087-5 · Cited by 89
Dancu, M. B., Berardi, D. E., Heuvel, J. P. V., & Tarbell, J. M. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000143855.85343.0e · Cited by 89
Fischer, L., Schlienger, R. G., Matter, C. M., Jick, H., & Meier, C. R. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.22.2472 · Cited by 86
Singh, G., Miller, J. D., Huse, D. M., et al. (2003) · PubMed · Cited by 85
Expression of Cyclo-oxygenase-2 in Human Atherosclerotic Carotid Arteries
Stemme, V., Swedenborg, J., Claesson, H. E., & Hansson, G. K. (2000) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.2000.1145 · Cited by 84
Clinical pharmacology of etoricoxib: a novel selective COX-2 inhibitor
Patrignani, P., Capone, M. L., & Tacconelli, S. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.2.265 · Cited by 84
Bishop‐Bailey, D., Pepper, J., Larkin, S. W., & Mitchell, J. A. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.10.1655 · Cited by 83
Self-citationAspirin: new cardiovascular uses for an old drug
Patrono, C. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00645-8 · Cited by 83
Cloning and Characterization of Cyclooxygenase-1b (Putative Cyclooxygenase-3) in Rat
Snipes, J. A., Kis, B., Shelness, G. S., Hewett, J. A., & Busija, D. W. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079533 · Cited by 82
Therland, K. L., Stubbe, J., Thiesson, H. C., Ottosen, P. D., Walter, S., Sørensen, G. L., Skøtt, O., & Jensen, B. L. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000124673.79934.24 · Cited by 73
Cyclooxygenase-2 as a therapeutic target
Mitchell, J. A., & Evans, T. W. (1998) · Inflammation Research · doi:10.1007/s000110050287 · Cited by 72
Self-citationSelective Cyclooxygenase-2 Inhibition and Cardiovascular Effects
Shaya, F. T. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.2.181 · Cited by 67
Aspirin insensitive eicosanoid biosynthesis in cardiovascular disease
Patrignani, P. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00382-7 · Cited by 63
Alsalameh, S., Burian, M., Mahr, G., Woodcock, B. G., & Geißlinger, G. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01460.x · Cited by 61
Induction of Cyclooxygenase-2 in Human Saphenous Vein and Internal Mammary Artery
Bishop‐Bailey, D., Pepper, J., Haddad, E. B., Newton, R. C., Larkin, S. W., & Mitchell, J. A. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1644 · Cited by 60
Self-citationDilger, K., Herrlinger, C., Peters, J., Seyberth, H. W., Schweer, H., & Klotz, U. E. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127000204200905 · Cited by 59
Yoshisue, H., Suzuki, K., Kawabata, A., Ohya, T., Zhao, H., Sakurada, K., Taba, Y., Sasaguri, T., Sakai, N., Yamashita, S., et al. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00735-3 · Cited by 59
Role of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle
Jiménez, R., Belcher, E., Sriskandan, S., Lucas-Domínguez, R., McMaster, S. K., Vojnovic, I., Warner, T. D., & Mitchell, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407655101 · Cited by 56
Self-citationRaising the Safety Bar — The FDA's Coxib Meeting
Okie, S. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058055 · Cited by 56
Non-steroidal anti-inflammatory drugs and the continuum of renal dysfunction.
Epstein, M. (2002) · PubMed · Cited by 55
Weber, A., Przytulski, B., Schumacher, M., Zimmermann, N., Gams, E., Hohlfeld, T., & Schrör, K. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03423.x · Cited by 55
Warner, T. D., Vojnovic, I., Giuliano, F., Jiménez, R., Bishop‐Bailey, D., & Mitchell, J. A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.063875 · Cited by 51
Self-citationNomenclature for COX-2 Inhibitors
Vane, J. R., & Warner, T. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02837-3 · Cited by 50
Self-citationPerini, R. F., Fiorucci, S., & Wallace, J. L. (2004) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2004/890585 · Cited by 50
Warabi, E., Wada, Y., Kajiwara, H., Kobayashi, M., Koshiba, N., Hisada, T., Shibata, M., Ando, J., Tsuchiya, M., Kodama, T., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.05.020 · Cited by 50
HAMILTON, L. C., Mitchell, J. A., Tomlinson, A., & Warner, T. D. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.2.245 · Cited by 49
Self-citationDeficiency of COX-1 causes natriuresis and enhanced sensitivity to ACE inhibition
Athirakul, K., Kim, H., Audoly, L., Smithies, O., & Coffman, T. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00072.x · Cited by 49
Aronoff, D. M., Boutaud, O. G., Marnett, L. J., & Oates, J. A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042853 · Cited by 39
Censarek, P., Freidel, K., Udelhoven, M., Ku, S.-J., Hohlfeld, T., Meyer-Kirchrath, J., Schrör, K., & Weber, A. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-05-0302 · Cited by 35
Constitutive Expression and Involvement of Cyclooxygenase-2 in Human Megakaryocytopoiesis
Tanaka, N., Sato, T., Fujita, H., & Morita, I. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000117181.68309.10 · Cited by 32
Dilger, K., Herrlinger, C., Peters, J., Seyberth, H. W., Schweer, H., & Klotz, U. E. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127002401102902 · Cited by 24
Hypertension in the patient with arthritis: have we been underestimating its significance?
Day, R. O. (2003) · PubMed · Cited by 8
Cited by
Carbaboranes as Pharmacophores: Properties, Synthesis, and Application Strategies
Scholz, M., & Hey-Hawkins, E. (2011) · Chemical Reviews · doi:10.1021/cr200038x · Cited by 797
Rao, P., & Knaus, E. E. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3t886 · Cited by 773
Clinical Pharmacology of Non-Steroidal Anti-Inflammatory Drugs: A Review
Bacchi, S., Palumbo, P., Sponta, A., & Coppolino, M. F. (2012) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/187152312803476255 · Cited by 433
Shafi, S., Mahboob Alam, M., Mulakayala, N., Mulakayala, C., Vanaja, G., Kalle, A. M., Pallu, R., & Alam, M. S. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.01.032 · Cited by 301
Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium
Mitchell, J. A., Ali, F., Bailey, L., Moreno, L., & Harrington, L. S. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.038588 · Cited by 291
Self-citation
Metadata
- Authors
- Mitchell, J. A., & Warner, T. D.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2006-01
- Volume
- 5
- Issue
- 1
- Pages
- 75-86
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1986383551
- Cited by
- 279
- References
- 119
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.